Online citations, reference lists, and bibliographies.
← Back to Search

Effects Of Postoperative Mediastinal Radiation On Completely Resected Stage II And Stage III Epidermoid Cancer Of The Lung. LCSG 773.

T. Weisenburger
Published 1994 · Medicine

Cite This
Download PDF
Analyze on Scholarcy
Share
Among patients with lung cancer approximately 44% have disease limited to the chest. Patients with early lesions treated surgically have better survival rates than those with more advanced primary disease or nodal involvement. Postoperative irradiation should reduce local or regional recurrence and hopefully reduce systemic relapse.
This paper references
10.1016/S0003-4975(10)60786-2
Mediastinal metastases in bronchogenic carcinoma: influence of postoperative irradiation, cell type, and location.
M. Kirsh (1982)
10.1097/00000421-198212000-00014
Toxicity and response criteria of the Eastern Cooperative Oncology Group
M. Oken (1982)
10.2307/2987141
Statistical methods
G. W. Snedecor (1980)
10.1007/978-1-4612-4380-9_25
Nonparametric Estimation from Incomplete Observations
E. L. Kaplan (1958)
10.1080/01621459.1963.10500879
Chi-square tests with one degree of freedom
N. Mantel (1963)
Regression Models and Life-Tables
D.
Postoperative mediastinal radi
J Mastrandrea (1991)
10.1161/01.CIR.61.3.508
Clinical Judgment and Statistics: Lessons from a Simulated Randomized Trial in Coronary Artery Disease
K. Lee (1980)
10.1056/NEJM198706043162311
No evidence for segregation distortion in diabetes.
MacDonald Mj (1987)
10.1378/CHEST.89.4_SUPPLEMENT.225S
The new International Staging System for Lung Cancer.
C. Mountain (1987)
Evaluation of survival data and two new rank order statistics arising in its consideration.
N. Mantel (1966)
10.1378/CHEST.106.6_SUPPLEMENT.293S
Surgical adjuvant therapy for stage II and stage III adenocarcinoma and large cell undifferentiated carcinoma.
E. Holmes (1994)
10.1016/0003-4975(94)91335-8
Results of surgical resection in patients with N2 non-small cell lung cancer.
D. Miller (1994)
10.1016/S0039-6109(16)44330-6
A new international staging system for lung cancer.
C. Mountain (1986)
The lung and thymus
JD Cox (1987)
10.1056/NEJM198706043162310
Postoperative mediastinal radiation for cancer of the lung.
J. Cox (1987)
10.1200/JCO.1984.2.12.1352
Sites of recurrence in resected stage I non-small-cell lung cancer: a guide for future studies.
R. Feld (1984)
10.1093/MILMED/141.8.521
Department of Health, Education, and Welfare.
T. Cooper (1976)
postoperative radiotherapy of bronchogenic carcinoma
DL Miller (1980)
10.1093/BIOMET/66.3.419
Comparison of four tests for equality of survival curves in the presence of stratification and censoring
Lloyd Ltntnger (1979)
10.1148/116.2.405
Postresection irradiation for primary lung cancer.
N. Green (1975)
10.1016/S0003-4975(10)63881-7
Carcinoma of the lung: results of treatment over ten years.
M. Kirsh (1976)
10.1200/JCO.1986.4.5.710
Surgical adjuvant therapy for stage II and stage III adenocarcinoma and large-cell undifferentiated carcinoma.
E. Holmes (1986)
10.1016/0360-3016(80)90199-6
Basis for new strategies in postoperative radiotherapy of bronchogenic carcinoma.
N. Choi (1980)
10.1016/0360-3016(91)90217-R
Controversies in the role of postoperative radiotherapy in stages II and IIIA resected non-small cell lung carcinoma.
N. Choi (1991)
10.1378/chest.106.6.297s
Effects of postoperative mediastinal radiation on completely resected stage II and stage III epidermoid cancer of the lung.
T. Weisenburger (1986)



This paper is referenced by
10.1016/S0003-4975(99)00715-8
Postoperative adjuvant therapy for stage II non-small-cell lung cancer.
J. Park (1999)
10.1016/S0169-5002(04)80039-4
Adjuvant treatment of lung cancer: current status and potential applications of new regimens.
T. Le Chevalier (2004)
10.1016/J.IJROBP.2006.02.007
Patterns of failure after resection of non-small-cell lung cancer: implications for postoperative radiation therapy volumes.
C. Kelsey (2006)
10.1016/S0003-4975(97)82827-5
Survival and prognosis after pneumonectomy for lung cancer in the elderly.
Y. Mizushima (1997)
10.1002/(SICI)1520-6823(1999)7:1<49::AID-ROI7>3.0.CO;2-8
Results of a phase II concurrent chemoradiotherapy study using three-dimensional conformal radiotherapy with cisplatin and oral etoposide in stage III nonsmall-cell lung cancer.
L. Chen (1999)
10.1002/(SICI)1097-0142(19991001)86:7<1189::AID-CNCR13>3.0.CO;2-N
Induction chemotherapy employing dose‐intense cisplatin with mitomycin and vinblastine (MVP400), followed by thoracic surgery or irradiation, for patients with stage III nonsmall cell lung carcinoma
K. Ng (1999)
10.1186/1756-8722-2-1
Radical cyberknife radiosurgery with tumor tracking: an effective treatment for inoperable small peripheral stage I non-small cell lung cancer
B. Collins (2009)
10.1016/j.ijrobp.2012.03.018
Surgical management of early-stage non-small cell lung carcinoma and the present and future roles of adjuvant therapy: a review for the radiation oncologist.
Laura N. Medford-Davis (2012)
10.3816/CLC.2004.N.022
Early-stage non-small-cell lung cancer: current perspectives in combined-modality therapy.
P. Bunn (2004)
10.1016/J.SEMRADONC.2004.07.005
Adjuvant chemotherapy and radiotherapy in non-small cell lung cancer.
M. Erman (2004)
10.1016/S0360-3016(97)00772-4
Spinal cord localization in the treatment of lung cancer: use of radiographic landmarks.
R. Miller (1998)
10.1634/THEONCOLOGIST.1-4-201
Diagnosis and Treatment of Early-Stage Non-Small Cell Lung Cancer.
Olak (1996)
10.3349/ymj.2012.53.6.1120
High Dose Involved Field Radiation Therapy as Salvage for Loco-Regional Recurrence of Non-Small Cell Lung Cancer
S. H. Bae (2012)
10.3389/fonc.2019.00786
Trends of Postoperative Radiotherapy for Completely Resected Non-small Cell Lung Cancer in China: A Hospital-Based Multicenter 10–Year (2005–2014) Retrospective Clinical Epidemiological Study
Y. Men (2019)
10.1016/j.cllc.2017.06.009
Quantitatively Excessive Normal Tissue Toxicity and Poor Target Coverage in Postoperative Lung Cancer Radiotherapy Meta‐analysis
Y. Abuodeh (2018)
10.1016/S0169-5002(97)00643-0
The limits of surgical resection alone for non-small cell lung cancer.
M. Johnston (1997)
10.1016/S0169-5002(01)00300-2
Postoperative radiotherapy in localized non-small cell lung cancer.
C. Ruebe (2001)
10.1016/J.RADONC.2007.04.004
The role of radiotherapy in lung cancer: where is the evidence?
J. Jassem (2007)
10.1002/14651858.CD002142.PUB4
Postoperative radiotherapy for non-small cell lung cancer.
S. Burdett (2000)
10.1007/BF01659082
Neoadjuvant and adjuvant therapy in the management of locally advanced non-small-cell lung cancer
M. Jaklitsch (2005)
10.1378/CHEST.123.1_SUPPL.202S
Treatment of stage IIIA non-small cell lung cancer.
L. Robinson (2003)
10.1510/icvts.2007.174342
Postoperative radiotherapy for patients with completely resected pathological stage IIIA-N2 non-small cell lung cancer: focusing on an effect of the number of mediastinal lymph node stations involved.
H. Matsuguma (2008)
10.1007/174_2010_108
Cancer of the Lung
Joe Y Chang (2010)
10.6004/JNCCN.2010.0056
Non-small cell lung cancer clinical practice guidelines in oncology.
David S. Ettinger (2006)
10.1016/S0360-3016(98)00508-2
Predictors of subclinical nodal involvement in clinical stages I and II non-small cell lung cancer: implications in the inoperable and three-dimensional dose-escalation settings.
T. E. Sawyer (1999)
10.1093/JJCO/HYE015
Intra-thoracic failure pattern and survival status following 3D conformal radiotherapy for non-small cell lung cancer: a preliminary report.
C. Chien (2001)
10.1016/S0003-4975(01)02878-8
A response to "Clinical trials in lung cancer: truth, justice, and the American way".
F. Grannis (2001)
10.1016/S0167-8140(02)00306-7
Analysis of dose distribution in the 'Rind'--a volume outside the PTV--in 3-dimensional conformal radiation therapy of non-small cell lung cancer.
C. McGibney (2003)
10.1016/J.LUNGCAN.2003.09.020
Postoperative radiotherapy in stage II or IIIA completely resected non-small cell lung cancer: a systematic review and practice guideline.
G. Okawara (2004)
10.1038/sj.bjc.6601624
Preoperative concurrent chemoradiotherapy with cisplatin and docetaxel in patients with locally advanced non-small-cell lung cancer
H. Katayama (2004)
10.1053/SRAO.2000.9613
Counterpoint: better radiation treatment of non-small cell lung cancer using new techniques without elective nodal irradiation.
T. Williams (2000)
10.1097/JTO.0b013e3181c20080
Timing of Local and Distant Failure in Resected Lung Cancer: Implications for Reported Rates of Local Failure
Jessamy A. Boyd (2010)
See more
Semantic Scholar Logo Some data provided by SemanticScholar